Explore our premium grade raw materials and pharmaceutical-grade carrier ingredients optimized for commercial liquid suspensions, syrups, and functional dietary shots.
Zeon Lifesciences operates state-of-the-art cGMP, US FDA-registered, and FSSC 22000 validated production complexes delivering turn-key liquid solutions for 60+ countries.
Our dedicated oral liquid infrastructure processes solutions, syrups, botanical suspensions, and nano-emulsions. Utilizing high-shear inline homogenizers and temperature-controlled jacketed vessels, we ensure homogenous active distribution and physical stability across 24-month shelf cycles.
Backed by Intertek FSSC 22000 certification, US FDA facility registration, HACCP, Halal, and AYUSH licensing. Every batch undergoes rigorous HPLC assay testing, heavy metal mass spectrometry, and microbiological validation before international dispatch.
We provide full Common Technical Document (CTD) formats, Free Sale Certificates (FSC), Certificate of Analysis (COA), real-time stability protocol studies, and complete labeling compliance matching EU CE, US FDA, and GCC health authority standards.
Information Gain Perspective: Achieving European Conformity (CE) and global compliance for oral liquid preparations requires solving two primary engineering challenges: chemical degradation caused by aqueous oxidation and organoleptic palatability without compromising bioactive integrity.
Hydrophobic active pharmaceutical ingredients (APIs) and botanical extracts pose significant bioavailability hurdles in liquid form. By utilizing macrocyclic host molecules like Alpha-Cyclodextrin, our formulation scientists encapsulate hydrophobic compounds into hydrophilic outer shells. This process increases aqueous solubility up to 300% while masking astringent botanical tastes.
Modern consumers demand preservative-free or natural preservation systems. We implement dual-stage preservation: physical thermal pasteurization combined with pH control utilizing natural organic acids. Inert nitrogen sparging during filling removes headspace oxygen, preventing oxidation of delicate vitamins and herbal compounds.
For insoluble mineral salts and micronized botanical solids, preventing phase separation or sedimentation is critical. We engineer thixotropic fluid dynamics using natural hydrocolloids. These matrices maintain high viscosity at rest—preventing particles from settling—while reducing viscosity under agitation to ensure accurate, smooth pouring.
| Liquid Delivery Platform | Target Active Category | Bioavailability Rate | Packaging Compatibility | Key Technical Advantage |
|---|---|---|---|---|
| Micro-Emulsion Shots (25ml - 60ml) | Lipid-soluble Nutrients, CoQ10, Curcumin | Ultra-High (90-95%) | PET Bottlets, Glass Vials, HDPE Shots | Rapid gastric absorption bypasses primary liver metabolism. |
| Viscous Functional Syrups | Pediatric Vitamins, Cough & Immune Botanicals | High (75-85%) | Amber PET/Glass Bottles with Dosing Cups | Enhanced mucosal adhesion and prolonged throat contact time. |
| Single-Dose Oral Liquids (10ml Ampoules) | Concentrated Tonics, Hydrolyzed Collagen | Very High (85-90%) | Blow-Fill-Seal (BFS) Polypropylene Ampoules | Zero contamination risk, precise single-unit administration. |
| Aqueous Oral Drops | Infant Vitamin D3, Probiotic Suspensions | Maximum Hydrolytic Delivery | Glass Dropper Bottles with Calibrated Pipettes | Micro-dosing accuracy for sensitive patient populations. |
Strategic analysis for B2B sourcing directors, pharmaceutical brand owners, and procurement managers targeting global expansion.
Traditional large-bottle formats are rapidly giving way to portable 25ml–60ml ready-to-drink (RTD) liquid shots. Brand owners prioritize shot packaging due to higher consumer compliance, premium pricing potential, and elimination of post-opening oxidation risks.
Procurement teams are actively replacing conventional liquid suspensions with liposomal delivery systems. Phospholipid-bilayer encapsulation shields active molecules from gastric acid degradation, facilitating direct cellular uptake and allowing lower active dosage with superior physiological outcomes.
High-fructose corn syrup bases are completely obsolete in modern CE-marked liquid formulations. Global buyers now mandate natural polyol carriers such as Erythritol, Xylitol, or Plant-Derived Glycerin combined with Stevia, ensuring pediatric safety and diabetic compatibility.
European environmental mandates (EU Packaging and Packaging Waste Regulation) require contract manufacturers to provide post-consumer recycled (PCR) PET bottles, lightweight glass ampoules, and aluminum caps, minimizing total carbon footprint across international supply chains.
Our dedicated formulation research center houses advanced analytical equipment including High-Performance Liquid Chromatography (HPLC), Gas Chromatography (GC), UV-Vis Spectrophotometers, and accelerated stability test chambers. We take your concept from lab-scale bench trials to commercial high-volume execution seamlessly.
Whether you require pilot validation batches of 5,000 units for clinical trials or commercial manufacturing runs of millions of bottles, our modular liquid suites offer agile scale-up without requiring formula re-validation or altering physical parameters.
From custom active ingredient sourcing (botanicals, bioactive peptides, vitamins) to primary packaging design, secondary carton assembly, sleeve labeling, and export freight management—our dedicated project managers handle the entire manufacturing workflow.
Every commercial dispatch includes a comprehensive quality dossier: Batch Certificate of Analysis (COA), Master Formulation Record summary, Stability Testing Data (Accelerated & Real-time under ICH climatic zone conditions), Heavy Metals & Pesticide Analysis Report, Microbiological Clearance Certificate, and Certificate of Origin.
Standard commercial MOQs start at 10,000 units for standard PET/glass bottled liquids and 30,000 units for specialized single-dose liquid shots or ampoules. Pilot trial batches for clinical evaluation or market testing can be arranged under specific R&D agreements.
We utilize multi-tiered stabilization strategies: precise microencapsulation (e.g., Alpha-Cyclodextrin complexation), pH optimization using food-grade buffers, light-blocking amber packaging materials, and de-aeration/nitrogen flushing during liquid compounding to prevent oxidative degradation.
Yes. Our clean-room blending suites routinely produce sugar-free, gluten-free, non-GMO, allergen-free, and vegan-certified liquid formulations. We replace sugar bases with high-purity Sorbitol, Glycerin, Erythritol, or natural Stevia extracts tailored to your target market regulations.
We offer a diverse spectrum of primary packaging solutions: PET and Glass bottles (30ml to 500ml) with tamper-evident caps or measuring cups, 25ml–60ml HDPE energy/wellness shot containers, 10ml–15ml stick-packs, and glass/plastic single-dose liquid ampoules.
Standard turn-around for custom formulation development, taste optimization, and lab sample sign-off is 2 to 4 weeks. Following sample approval, pilot batch production, stability initiation, and full commercial manufacturing typically take 4 to 6 weeks.
Partner with an established US FDA-registered and FSSC 22000 certified CDMO leader. Contact our technical engineering team today to review formulations, request product samples, or schedule a facility audit.
